ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 155 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,533 | -47.8% | 2,823 | 0.0% | 0.00% | – |
Q2 2023 | $60,412 | -47.1% | 2,823 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $114,162 | -21.9% | 2,823 | -10.2% | 0.00% | 0.0% |
Q4 2022 | $146,166 | -12.5% | 3,142 | -2.1% | 0.00% | 0.0% |
Q3 2022 | $167,000 | +9.9% | 3,210 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $152,000 | -34.2% | 3,210 | -0.9% | 0.00% | 0.0% |
Q1 2022 | $231,000 | +9.5% | 3,240 | +14.8% | 0.00% | 0.0% |
Q4 2021 | $211,000 | +31.9% | 2,823 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $160,000 | +29.0% | 2,823 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $124,000 | -10.8% | 2,823 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $139,000 | +16.8% | 2,823 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $119,000 | -7.8% | 2,823 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $129,000 | -9.2% | 2,823 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $142,000 | +163.0% | 2,823 | +168.6% | 0.00% | 0.0% |
Q1 2020 | $54,000 | -16.9% | 1,051 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $65,000 | +51.2% | 1,051 | +48.0% | 0.00% | – |
Q3 2019 | $43,000 | -28.3% | 710 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $60,000 | -11.8% | 710 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $68,000 | +41.7% | 710 | +4.7% | 0.00% | – |
Q4 2018 | $48,000 | -17.2% | 678 | 0.0% | 0.00% | – |
Q3 2018 | $58,000 | -9.4% | 678 | +23.5% | 0.00% | -100.0% |
Q2 2018 | $64,000 | +45.5% | 549 | 0.0% | 0.00% | – |
Q1 2018 | $44,000 | +37.5% | 549 | 0.0% | 0.00% | – |
Q4 2017 | $32,000 | +23.1% | 549 | 0.0% | 0.00% | – |
Q3 2017 | $26,000 | +30.0% | 549 | 0.0% | 0.00% | – |
Q2 2017 | $20,000 | +185.7% | 549 | +133.6% | 0.00% | – |
Q1 2017 | $7,000 | -12.5% | 235 | 0.0% | 0.00% | – |
Q4 2016 | $8,000 | +33.3% | 235 | 0.0% | 0.00% | – |
Q3 2016 | $6,000 | +20.0% | 235 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | -28.6% | 235 | 0.0% | 0.00% | – |
Q1 2016 | $7,000 | -12.5% | 235 | 0.0% | 0.00% | – |
Q4 2015 | $8,000 | 0.0% | 235 | 0.0% | 0.00% | – |
Q3 2015 | $8,000 | -27.3% | 235 | 0.0% | 0.00% | – |
Q2 2015 | $11,000 | +57.1% | 235 | 0.0% | 0.00% | – |
Q1 2015 | $7,000 | – | 235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |